Scher, Jose U.
NYU Grossman School of Medicine,
United States
2025 Rank: 32,518
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 185 out of 43,105 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32,518 | 33,530 |
| Total Cites | 1,153 | 1,260 |
| H-index | 18 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 397 | 406 |
| Number of Single+First+Last Authored Papers | 58 | 58 |
| Total Cites to Single+First+Last Authored Papers | 666 | 698 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 975 | 1,045 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
8.49%
|
|
Scher, Jose U.
NYU Grossman School of Medicine,
United States
2024 Rank: 31,834
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 182 out of 40,382 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31,834 | 34,097 |
| Total Cites | 1,135 | 1,226 |
| H-index | 18 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 342 | 353 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 641 | 668 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 934 | 998 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
7.42%
|
|
Scher, Jose U.
NYU Langone Health,
United States
2023 Rank: 24,483
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Immunology
Rank in SubField 1: 157 out of 37,656 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24,483 | 24,204 |
| Total Cites | 1,320 | 1,452 |
| H-index | 20 | 21 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 4 | 5 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 419 | 438 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 790 | 833 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,115 | 1,193 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.22 |
| Self-Citation Percentage |
9.09%
|
|
Scher, Jose U.
NYU Grossman School of Medicine,
United States
2022 Rank: 23,896
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Immunology
Rank in SubField 1: 158 out of 35,286 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23,896 | 24,285 |
| Total Cites | 1,163 | 1,295 |
| H-index | 19 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 414 | 430 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 738 | 774 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 993 | 1,087 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.19 |
| Self-Citation Percentage |
10.19%
|
|
Scher, Jose U.
NYU Grossman School of Medicine,
United States
2021 Rank: 30,138
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Immunology
Rank in SubField 1: 187 out of 32,862 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30,138 | 31,137 |
| Total Cites | 1,456 | 1,591 |
| H-index | 19 | 20 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 570 | 598 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 999 | 1,051 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,244 | 1,335 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.19 |
| Self-Citation Percentage |
8.49%
|
|
Scher, Jose U.
NYU Langone Health,
United States
2020 Rank: 34,343
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Immunology
Rank in SubField 1: 207 out of 29,160 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34,343 | 34,237 |
| Total Cites | 772 | 838 |
| H-index | 16 | 17 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 9 | 10 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 449 | 471 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 596 | 627 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 611 | 652 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
7.88%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.